| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |